Tonsillar tuberculosis in a rheumatoid arthritis patient receiving anti-TNFalpha (adalimumab) treatment. [electronic resource]
Producer: 20050419Description: 112-4 p. digitalISSN:- 0300-2977
- Adalimumab
- Anti-Bacterial Agents
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Antitubercular Agents -- therapeutic use
- Arthritis, Rheumatoid -- blood
- DNA, Bacterial -- analysis
- Diagnosis, Differential
- Drug Therapy, Combination -- therapeutic use
- Humans
- Male
- Middle Aged
- Mycobacterium tuberculosis -- genetics
- Palatine Tonsil -- microbiology
- Polymerase Chain Reaction
- Risk Factors
- Tuberculosis, Laryngeal -- diagnosis
- Tuberculosis, Pulmonary -- diagnosis
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.